To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

FGF4 and retinoic acid di… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

FGF4 and retinoic acid direct differentiation of hESCs into PDX1-expressing foregut endoderm in a time- and concentration-dependent manner.

Journal article
Authors Martina Johannesson
Anders Ståhlberg
Jacqueline Ameri
Fredrik Wolfhagen Sand
Karin Norrman
Henrik Semb
Published in PloS one
Volume 4
Issue 3
Pages e4794
ISSN 1932-6203
Publication year 2009
Published at Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Pages e4794
Language en
Keywords Activins, pharmacology, Cell Differentiation, drug effects, Cells, Cultured, drug effects, metabolism, Dose-Response Relationship, Drug, Drug Synergism, Embryonic Stem Cells, cytology, drug effects, metabolism, Endoderm, cytology, drug effects, metabolism, Fibroblast Growth Factor 4, physiology, Gene Expression Regulation, drug effects, Homeodomain Proteins, biosynthesis, genetics, Humans, Pancreas, cytology, embryology, Pyrroles, pharmacology, RNA, Messenger, biosynthesis, Receptor, Fibroblast Growth Factor, Type 2, antagonists & inhibitors, biosynthesis, genetics, physiology, Receptors, Retinoic Acid, biosynthesis, genetics, Signal Transduction, drug effects, physiology, Time Factors, Trans-Activators, biosynthesis, genetics, Tretinoin, pharmacology, Up-Regulation, drug effects, Wnt Proteins, physiology
Subject categories Medical and Health Sciences


BACKGROUND: Retinoic acid (RA) and fibroblast growth factor 4 (FGF4) signaling control endoderm patterning and pancreas induction/expansion. Based on these findings, RA and FGFs, excluding FGF4, have frequently been used in differentiation protocols to direct differentiation of hESCs into endodermal and pancreatic cell types. In vivo, these signaling pathways act in a temporal and concentration-dependent manner. However, in vitro, the underlying basis for the time of addition of growth and differentiation factors (GDFs), including RA and FGFs, as well as the concentration is lacking. Thus, in order to develop robust and reliable differentiation protocols of ESCs into mature pancreatic cell types, including insulin-producing beta cells, it will be important to mechanistically understand each specification step. This includes differentiation of mesendoderm/definitive endoderm into foregut endoderm--the origin of pancreatic endoderm. METHODOLOGY/PRINCIPAL FINDINGS: Here, we provide data on the individual and combinatorial role of RA and FGF4 in directing differentiation of ActivinA (AA)-induced hESCs into PDX1-expressing cells. FGF4's ability to affect endoderm patterning and specification in vitro has so far not been tested. By testing out the optimal concentration and timing of addition of FGF4 and RA, we present a robust differentiation protocol that on average generates 32% PDX1(+) cells. Furthermore, we show that RA is required for converting AA-induced hESCs into PDX1(+) cells, and that part of the underlying mechanism involves FGF receptor signaling. Finally, further characterization of the PDX1(+) cells suggests that they represent foregut endoderm not yet committed to pancreatic, posterior stomach, or duodenal endoderm. CONCLUSION/SIGNIFICANCE: In conclusion, we show that RA and FGF4 jointly direct differentiation of PDX1(+) foregut endoderm in a robust and efficient manner. RA signaling mediated by the early induction of RARbeta through AA/Wnt3a is required for PDX1 expression. Part of RA's activity is mediated by FGF signaling.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?